Adrenalectomy increases serotonin turnover in brains of obese Zucker rats

V. Routh,J. Stern,B. Horwitz

DOI: https://doi.org/10.1016/0031-9384(95)00079-X

1995-09-01

Abstract:

What problem does this paper attempt to address?

Characteristics and Feasibility of Ambulatory Respiratory Assessment of Paediatric Neuromuscular Disease: an Observational Retrospective Study.

Cheng Zhang,Cui-jie Wei,Zhe Jin,Jing Ma,Yan-e Shen,Qing Yu,Yan-bin Fan,Hui Xiong,Cheng-li Que

DOI: https://doi.org/10.1080/00207454.2022.2042691

2022-01-01

International Journal of Neuroscience

Abstract:PURPOSE:To investigate the characteristics of respiratory involvement in Chinese paediatric neuromuscular disease (NMD) at early stage and to explore convenient monitoring methods. MATERIALS AND METHODS:Children with NMD (age < 18) diagnosed at a multidisciplinary joint NMD clinic at Peking University First Hospital from January 2016 to April 2021 were included. Overnight polysomnography (PSG) and pulmonary function test (PFT) data were analysed, and the characteristics of four groups: congenital muscular dystrophy (CMD), congenital myopathy, spinal muscular atrophy, and Duchenne muscular dystrophy (DMD) were compared. RESULTS:A total of 83 children with NMD were referred for respiratory assessment, of who 80 children underwent PSG; 41 performed spirometry and 38, both. The duration of pulse oxygen saturation (SpO2) <90% over apnoea and hypopnoea index (AHI) was lowest in DMD and significantly different from CMD (p = 0.033). AHI was positively correlated with the oxygen desaturation index (ODI) (r = 0.929, p = 0.000). The peak expiratory flow (PEF) were positively correlated with forced vital capacity (FVC), both as actual values and percent pred, respectively (r = 0.820, 0.719, p = 0.000). ROC derived sensitivity and specificity of prediction of AHI > 15/h or duration of SpO2<90% ≥ 60 min from FVC <51% pred was 75.8% and 85.7%, respectively. CONCLUSIONS:AHI and hypoxia burden were independent factors in children with NMD in PSG and attention needed to be paid in both. FVC might be a daytime predictor for significant sleep-disordered breathing or hypoxia. Nocturnal consecutive oximetry with diurnal peak flow measurement may be convenient and effective for home monitoring at early stage of respiratory involvement.
[11. Hallux valgus. b). 10-year results after Hohmann's operation in hallux valgus].

N. P. Wiasmitinow,H. Zollinger

1979-04-01

Abstract:
"De Novo" Hypercapnic Respiratory Failure Unmasking Neuromuscular Disorders: Experiences From a Tertiary Care Center and Review of Literature

Aditya Vijayakrishnan Nair,Madhavi Kandagaddala,Ajith Sivadasan,A T Prabhakar,Shalini Nair,Vivek Mathew,Sanjith Aaron,Mathew Alexander

DOI: https://doi.org/10.1097/CND.0000000000000465

2024-03-01

Abstract:Objectives: Neuromuscular disorders could have respiratory involvement early or late into illness. Rarely, patients may present with a hypercapnic respiratory failure (with minimal motor signs) unmasking an underlying disease. There are hardly any studies which have addressed the spectrum and challenges involved in management of this subset, especially in the real-world scenario. Methods: A retrospective study comprising consecutive patients hospitalized with hypercapnic respiratory failure as the sole/dominant manifestation. The clinical-electrophysiological spectrum, phrenic conductions, diaphragm thickness, and outcomes were analyzed. Results: Twenty-seven patients were included, the mean age was 47.29 (SD 15.22) years, and the median duration of respiratory symptoms was 2 months (interquartile range [IQR] 1-4). Orthopnea was present in 23 patients (85.2%) and encephalopathy in 8 patients (29.6%). Phrenic nerve latencies and amplitudes were abnormal in 83.3% and 95.6%, respectively. Abnormal diaphragm thickness was noted in 78.5%. Based on a comprehensive electrophysiological strategy and paraclinical tests, an etiology was established in all. Reversible etiologies were identified in 17 patients (62.9%). These included myasthenia gravis (anti-AChR and MuSK), inflammatory myopathy, riboflavin transporter deficiency neuronopathy, Pompe disease, bilateral phrenic neuritis, and thyrotoxicosis. Respiratory onset motor neuron disease was diagnosed in 8 patients (29.6%). Despite diaphragmatic involvement, a functional respiratory recovery was noted at discharge (45%) and last follow-up (60%). Predictors for good outcomes included female sex, normal nerve conductions, and recent-onset respiratory symptoms. Discussion: A good functional recovery was noted in most of the patients including respiratory onset motor neuron disease. A systematic algorithmic approach helps in proper triaging, early diagnosis, and treatment. Clinical and electrodiagnostic challenges and observations from a tertiary care referral center are discussed.
Virulence of Curvularia in a murine model

Katihuska Paredes,J. Capilla,D. Sutton,E. Mayayo,A. Fothergill,J. Guarro

DOI: https://doi.org/10.1111/myc.12064

2013-02-26

Abstract:We have evaluated the virulence of two clinically relevant species of Curvularia; Curvularia spicifera and C. hawaiiensis, using an experimental model of disseminated infection in immunocompromised mice. Several inocula were tested over a range 1 × 103–1 × 106 colony‐forming units/animal. Both species had a similar behaviour, producing a high mortality. Tissue burden and histopathology studies demonstrated that lung was the organ most affected.
Effective non-invasive ventilation reduces muscle sympathetic nerve activity in patients with stable hypercapnic COPD

Binaya Regmi,Chiara Borrelli,Alberto Giannoni,Florian Kahles,Vaughan G. Macefield,Michael Dreher,Jens Spiesshoefer

DOI: https://doi.org/10.1007/s10286-024-01027-2

2024-03-20

Clinical Autonomic Research

Abstract:Increased sympathetic drive is of prognostic significance in chronic obstructive pulmonary disease (COPD) but its determinants remain poorly understood. One potential mechanism may be chemoreflex-mediated adrenergic stimulation caused by sustained hypercapnia. This study determined the impact of non-invasive ventilation (NIV) on muscle sympathetic nerve activity (MSNA) in patients with stable hypercapnic COPD. Ten patients (age 70 ± 7 years, GOLD stage 3–4) receiving long-term NIV (mean inspiratory positive airway pressure 21 ± 7 cmH 2 O) underwent invasive MSNA measurement via the peroneal nerve during spontaneous breathing and NIV. Compared with spontaneous breathing, NIV significantly reduced hypercapnia (PaCO 2 51.5 ± 6.9 vs 42.6 ± 6.1 mmHg, p < 0.0001) along with the burst rate (64.4 ± 20.9 vs 59.2 ± 19.9 bursts/min, p = 0.03) and burst incidence (81.7 ± 29.3 vs 74.1 ± 26.9 bursts/100 heartbeats, p = 0.04) of MSNA. This shows for the first time that correcting hypercapnia with NIV decreases MSNA in COPD.

neurosciences,clinical neurology
Is Hypercapnia Associated with Poor Prognosis in Chronic Obstructive Pulmonary Disease? A Long-Term Follow-Up Cohort Study.

Hui Yang,Pingchao Xiang,Erming Zhang,Weian Guo,Yanwei Shi,Shuo Zhang,Zhaohui Tong

DOI: https://doi.org/10.1136/bmjopen-2015-008909

IF: 3.006

2015-01-01

BMJ Open

Abstract:OBJECTIVES:To assess whether hypercapnia may predict the prognosis in chronic obstructive pulmonary disease (COPD).DESIGN:Prospective cohort study comparing the survival of patients with COPD and normocapnia to those with chronic hypercapnia.SETTING:Patients with consecutive COPD were enrolled between 1 May 1993 and 31 October 2006 at two medical centres. Follow-up was censored on 31 October 2011.PARTICIPANTS:A total of 275 patients with stable COPD and aged 40-85 years were enrolled. Diagnosis of hypercapnia was confirmed by blood gas analysis. Patients with near-terminal illness or comorbidities that affect PaCO2 (obstructive sleep apnoea, obesity-related hypoventilation, or neuromuscular disease) were excluded. The outcome of 98 patients with normocapnia and 177 with chronic hypercapnia was analysed.OUTCOME MEASURES:Overall survival.RESULTS:Median survival was longer in patients with normocapnia than in those with hypercapnia (6.5 vs 5.0 years, p=0.016). Multivariate COX regression analysis indicated that age (HR=1.043, 95% CI 1.012 to 1.076), Charlson Index, which is a measure of comorbidity (HR=1.172, 95% CI 1.067 to 1.288), use of medication (HR=0.565, 95% CI 0.379 to 0.842), body mass index (BMI) (HR=0.922, 95% CI 0.883 to 0.963), PaCO2 (HR=1.026, 95% CI 1.011 to 1.042), Cor pulmonale (HR=2.164, 95% CI 1.557 to 3.006), non-invasive positive-pressure ventilation (NPPV) (HR=0.615, 95% CI 0.429 to 0.881) and per cent of forced expiratory volume in 1 s (FEV1%) (HR=0.979, 95% CI 0.967 to 0.991), were independent risk factors for mortality.CONCLUSIONS:Increased age, Charlson Index, chronic hypercapnia and Cor pulmonale, and decreased FEV1%, use of medication, BMI and NPPV, were associated with a poor prognosis in patients with COPD.
Association between rate of change in PaCO2 and functional outcome for patients with hypercapnia after out-of-hospital cardiac arrest: Secondary analysis of a randomized clinical trial

Dawei Zhou,Yi Lv,Qing Lin,Chao Wang,Shuyang Fei,Wei He

DOI: https://doi.org/10.1016/j.ajem.2023.01.004

IF: 3.6

2023-03-01

The American Journal of Emergency Medicine

Abstract:BACKGROUND: Normocapnia is suggested for post resuscitation care. For patients with hypercapnia after cardiac arrest, the relationship between rate of change in partial pressure of carbon dioxide (PaCO2) and functional outcome was unknown.METHODS: This was the secondary analysis of Resuscitation Outcomes Consortium (ROC) amiodarone, lidocaine, and placebo (ALPS) trial. Patients with at least 2 PaCO2 recorded and the first indicating hypercapnia (PaCO2 > 45 mmHg) after return of spontaneous circulation (ROSC) were included. The rate of change in PaCO2 was calculated as the ratio of the difference between the second and first PaCO2 to the time interval. The primary outcome was modified Rankin Score (mRS), dichotomized to good (mRS 0-3) and poor (mRS 4-6) outcomes at hospital discharge. The independent relationship between rate of change in PaCO2 and outcome was investigated with multivariable logistic regression model.RESULTS: A total of 746 patients with hypercapnia were included for analysis, of which 264 (35.4%) patients had good functional outcome. The median rate of change in PaCO2 was 4.7 (interquartile range [IQR] 1.7-12) mmHg per hour. After adjusting for confounders, the rate of change in PaCO2 (odds ratio [OR] 0.994, confidence interval [CI] 0.985-1.004, p = 0.230) was not associated the functional outcome. However, rate of change in PaCO2 (OR 1.010, CI 1.001-1.019, p = 0.029) was independently associated with hospital mortality.CONCLUSIONS: For OHCA patients with hypercapnia on admission, the rate of change in PaCO2 was not independently associated with functional outcome; however, there was a significant trend that higher decreased rate was associated with increased hospital mortality.

emergency medicine
Hypercapnia and lung function parameters in chronic obstructive pulmonary disease

Lukas Gernhold,Claus Neurohr,Konstantinos Tsitouras,Nina Lutz,Selina Briese,Alessandro Ghiani

DOI: https://doi.org/10.1186/s12890-024-03151-1

IF: 3.1

2024-07-17

BMC Pulmonary Medicine

Abstract:In advanced chronic obstructive pulmonary disease (COPD), hypercapnia may occur due to severe bronchial obstruction with lung hyperinflation. Non-invasive ventilation (NIV) provides the standard of care intended to achieve physiological PCO 2 levels, thereby reducing overall mortality. The present study aimed to evaluate pulmonary function parameters derived from spirometry (forced vital capacity [FVC], forced expiratory volume in 1 s [FEV1]), body plethysmography (residual volume [RV], total lung capacity [TLC]), and lung diffusion capacity for carbon monoxide (single-breath method [DCO-SB], alveolar-volume corrected values [DCO-VA]) as predictors of chronic hypercapnia in patients with advanced COPD.

respiratory system
Early Fatal Pontocerebellar Hypoplasia with Simplified Cerebral Gyration and Pseudolissencephaly

Adrienne Hoffmann,P. Weber,C. Fallet-Bianco,E. Radü,A. Probst

DOI: https://doi.org/10.1159/000089296

2006-02-01

Fetal Diagnosis and Therapy

Abstract:We report the observation of a child born at 38 5/7 weeks’ gestation, who presented with marked microcephaly and suffered from persistent intractable epilepsy up to his death at the age of 5 days. Magnetic resonance imaging suggested lissencephaly. But interestingly no submicroscopical deletion in LIS-1 gene could be detected and true lissencephaly could not be confirmed histologically. Instead, primary degenerative process was considered the most probable cause of congenital pontocerebellar hypoplasia II in this case, which may be associated with a maturation delay of the cerebral hemispheres. The present case points to possible pitfalls in neuroradiological interpretation of simplified cerebral gyration and to the necessity to take into account cerebral pathologies leading to slowing or arrest of intrauterine cerebral development and delay of cerebral gyration.
Determining the effects of elevated partial pressure of oxygen on hypercapnia-induced cerebrovascular reactivity

Ece Su Sayin,James Duffin,Julien Poublanc,Lashmikumar Venkatraghavan,David John Mikulis,Joseph Arnold Fisher,Olivia Sobczyk

DOI: https://doi.org/10.1177/0271678X231197000

Abstract:Evaluation of cerebrovascular reactivity (CVR) to hypo- and hypercapnia is a valuable test for the assessment of vasodilatory reserve. While hypercapnia-induced CVR testing is usually performed at normoxia, mild hyperoxia may increase tolerability of hypercapnia by reducing the ventilatory distress. However, the effects of mild hyperoxia on CVR was unknown. We therefore recruited 21 patients with a range of steno-occlusive diseases and 12 healthy participants who underwent a standardized 13-minute step plus ramp CVR test with a carbon dioxide gas challenge at the subject's resting end-tidal partial pressure of oxygen or at mild hyperoxia (PetO2 = 150 mmHg) depending on to which group they were assigned. In 11 patients, the second CVR test was at normoxia to examine test-retest differences. CVR was defined as % Δ Signal/ΔPetCO2. We found that there was no significant difference between CVR test results conducted at normoxia and at mild hyperoxia for participants in Groups 1 and 2 for the step and ramp portion. We also found no difference between test and retest CVR at normoxia for patients with cerebrovascular pathology (Group 3) for step and ramp portion. We concluded normoxic CVR is repeatable, and that mild hyperoxia does not affect CVR.
Androgenic regulation of enzymes involved in DNA synthesis in epididymis of young rats.

O. Imanishi,M. Fujisawa,O. Matsumoto,S. Kamidono

DOI: https://doi.org/10.1530/JRF.0.0960355

1992-09-01

Abstract:In the epididymis of young rats, activities of DNA polymerases alpha, beta and gamma and DNA topoisomerase I decreased after castration. DNA polymerase alpha and gamma increased with androgen administration and activity reached 81.3% and 78.0%, respectively, of the activity in the sham-operated group on day 21. Activity of DNA polymerase beta remained at the activity of day 7 during androgen administration and was almost the same as that in the sham-operated group on day 21. DNA topoisomerase I activity showed a slight increase with androgen administration and reached 50.3% of that in the sham-operated group. The activities of these enzymes were not fully restored to those in the sham-operated group. These results indicate that in young rats activities of epididymal DNA polymerase alpha and gamma and DNA topoisomerase I are partially, and that of DNA polymerase beta wholly, dependent on androgens and may provide a means of investigating the regulation of epididymal cell proliferation.
Does PaCO2 correction have an impact on survival of patients with chronic respiratory failure and long-term non-invasive ventilation?

Audrey Thomas,Sandrine Jaffré,Vianney Guardiolle,Tanguy Perennec,Frédéric Gagnadoux,François Goupil,Cédric Bretonnière,Vivien Danielo,Jean Morin,François-Xavier Blanc

DOI: https://doi.org/10.1016/j.heliyon.2024.e26437

IF: 3.776

2024-02-18

Heliyon

Abstract:Background and objective: Non-invasive ventilation (NIV) improves survival of patients with chronic respiratory failure (CRF). Most often, pressure settings are made to normalize arterial blood gases. However, this objective is not always achieved due to intolerance to increased pressure or poor compliance. Few studies have assessed the effect of persistent hypercapnia on ventilated patients' survival. Data from the Pays de la Loire Respiratory Health Research Institute cohort were analyzed to answer this question. Study design and methods: NIV-treated adults enrolled between 2009 and 2019 were divided into 5 subgroups: obesity-hypoventilation syndrome (OHS), COPD, obese COPD, neuromuscular disease (NMD) and chest wall disease (CWD). PaCO2 correction was defined as the achievement of a PaCO2 < 6 kPa or a 20% decrease in baseline PaCO₂ in COPD patients. The endpoint was all-cause mortality. Follow-up was censored in case of NIV discontinuation. Results: Data from 431 patients were analyzed. Median survival was 103 months and 148 patients died. Overall, PaCO2 correction was achieved in 74% of patients. Bivariate analysis did not show any survival difference between patients who achievedPaCO₂ correction and those who remained hypercapnic: overall population: p = 0.74; COPD: p = 0.97; obese COPD: p = 0.28; OHS: p = 0.93; NMD: p = 0.84; CWD: p = 0.28. Conclusion: Moderate residual hypercapnia under NIV does not negatively impact survival in CRF patients. In individuals with poor tolerance of pressure increases, residual hypercapnia can therefore be tolerated under long-term NIV. Larger studies, especially with a higher number of patients with residual PaCO2 > 7 kPa, are needed to confirm these results.
Oximetry and carbon dioxide screening for ventilatory requirements in children with spinal muscular atrophy type 1-3

Archana Chacko,Peter D Sly,Robert S Ware,Emily Young,Jacob Robinson,Gordon Williams,Leanne M Gauld

DOI: https://doi.org/10.1016/j.sleep.2024.08.022

Abstract:Introduction: Despite disease modifying treatments (DMT), assisted ventilation is commonly required in children with Spinal Muscular Atrophy (SMA). Guidelines suggest screening with oximetry and transcutaneous carbon dioxide (TcCO2) for sleep disordered breathing (SDB). Aim: To determine the utility of pulse oximetry and TcCO2 as a screen for SDB and the need for Non-Invasive Ventilation (NIV) in children with SMA type 1-3. Methods: A prospective cohort study was conducted in Queensland, Australia. Full diagnostic PSG was completed in DMT naïve children with SMA. Pulse oximetry and TcCO2 were extracted from PSG. Apnoea-hypopnoea indices (AHI) criteria were applied to PSG results to define the need for NIV. Abnormal was defined as: ≤3 months of age [mo] AHI≥10 events/hour; >3mo AHI ≥5 events/hour. Receiver operating characteristic curves were calculated for abnormal PSG and pulse oximetry/TcCO2 variables, and diagnostic statistics were calculated. Results: Forty-seven untreated children with SMA were recruited (type 1 n = 13; 2 n = 21; 3 n = 13) ranging from 0.2 to 18.8 years old (median 4.9 years). Oxygen desaturation index ≥4 % (ODI4) ≥20events/hour had sensitivity 82.6 % (95 % CI 61.2-95.0) and specificity of 58.3 % (95 % CI 36.6-77.9). TcCO2 alone and combinations of oximetry/TcCO2 had low diagnostic ability. The same methodology was applied to 36 children who were treated (type 1 n = 7; type 2 n = 17; type n = 12) and oximetry±TcCO2 had low diagnostic ability. Conclusion: ODI4 ≥20events/hour can predict the need for NIV in untreated children with SMA. TcCO2 monitoring does not improve the PPV. If normal however, children may still require a diagnostic PSG. Neither oximetry nor TcCO2 monitoring were useful screening tests in the children treated with DMT.
Treatment of squamous cell carcinomas in head and neck with bleomycin and with combined bleomycin and x-rays.

P. Berdal,T. Ekroll,O. Iversen,R. Weyde

DOI: https://doi.org/10.3109/00016487309139731

IF: 1.698

Acta Oto-Laryngologica

Abstract:The choice of therapy for patients with squamous cell carcinoma will depend of the histology of the tumour, its extent and localization. X-rays and surgery, alone and combined, are well established methods by which elimination of the tumour may be achieved. With a new therapeutical approach, combining bleomycin and X-rays, a possible synergistic effect has been obtained. It has in itself given surprisingly good results and when used as a pre-operative treatment it offers possibilities of making an increased number of otherwise inoperable cases surgically accessible.
A Narrative Review of the Physiological Rationale and Clinical Evidence

Gabriele Pintaudi,Salvatore Lucio Cutuli,Tommaso Rosà,Teresa Michi,Alessandro Cardu,Filippo Bongiovanni,Massimo Antonelli,Domenico Luca Grieco

DOI: https://doi.org/10.3390/jcm13216350

IF: 3.9

2024-10-24

Journal of Clinical Medicine

Abstract:Acute hypercapnic respiratory failure is a life-threatening condition caused by alveolar hypoventilation. It is mostly caused by an acute exacerbation of chronic obstructive pulmonary disease or conditions yielding muscle dysfunction. Noninvasive ventilation through a facemask is the cornerstone first-line strategy to support hypercapnic patients with acidemia, and current guidelines strongly recommend this intervention to improve survival and long-term clinical outcomes. Because of its benefits related to carbon dioxide washout from the upper airways and the enhanced comfort, high-flow nasal oxygen has been proposed as a respiratory support strategy in patients with hypercapnic respiratory failure, both as an alternative to and in combination with noninvasive ventilation. When compared to noninvasive ventilation as a first-line intervention, high-flow nasal oxygen shows a higher rate of failure. Hence, if not contraindicated, the use of noninvasive ventilation should be preferred. After the resolution of acidemia with noninvasive ventilation, high-flow nasal oxygen showed promising physiological effects compared to conventional oxygen. During weaning from mechanical ventilation in patients with or at risk of developing hypercapnia, high-flow nasal oxygen showed encouraging results, especially when applied alternating with sessions of noninvasive ventilation. Optimal settings of high-flow nasal oxygen in hypercapnic patients include the use of a smaller-size cannula, flows ranging between 30 and 40 L/min, and FiO2 adjusted to obtain SpO2 between 88% and 92%. Specific interfaces, such as asymmetric cannulas, may further enhance the benefits of a high flow in terms of carbon dioxide clearance. In this narrative review, we provide an updated overview of the physiological rationale and clinical evidence concerning the use of high-flow nasal oxygen in patients with acute hypercapnic respiratory failure.

medicine, general & internal
[Application of capnography and SpO2 measurement in the evaluation of respiratory failure in patients with chronic obstructive pulmonary disease]

Jie Liu,Rong chang Chen,Nan-shan Zhong

Abstract:Objective: To investigate the accuracy and potential error range of noninvasive estimation of CO2 pressure (PCO2), arterial O2 pressure (PaO2), and oxygenation index (OI) by measuring the end-tidal CO2 pressure (PETCO2) and pulse oxygen saturation (SpO2) in patients with chronic obstructive pulmonary disease (COPD) and respiratory failure, and assess the feasibility of this method for dynamic monitoring of arterial CO2 pressure (PaCO2) and PaO2 in the primary care facilities where arterial blood gases analysis is not available. Methods: All the 30 patients with COPD and respiratory failure received routine clinical treatment including bronchodilators, mucolytics, glucocorticosteroid, antibiotics and oxygen therapy (titrated to keep SpO2 above 90%) for 5-7 days. A subgroup of the patients also received NIPPV treatment. All the patients were tested with both the eupnea method and prolonged expiratory method before and after the treatment to obtain the data of PCO2 and SpO2 were respectively performed before and after treatment. Results: The PETCO2 with eupnea (PETCO2(Q)) was 50.72-/+8.93 mmHg, significantly lower than PaCO2 (71.25-/+9.08 mmHg, Plt;0.01), but the PETCO2(P) (70.35-/+8.91 mmHg) was comparable with PaCO2 (P>0.05). Similar results were obtained after the treatment. The PETCO2(P) before treatment and after treatment was positively correlated to PaCO2 (r=0.96 and 0.97, respectively, P<0.01). The PaO2(Y) before the treatment derived from the oxygen dissociation curve based on SpO2 measurement was close to SpO2 (59.96-/+1.42 mmHg vs 59.07-/+2.22 mmHg, P>0.05). The OI derived from PaO2 and OI(Y) from PaO2 (Y) was also similar (215.70-/+22.77 vs 219.15-/+24.63, P>0.05). Linear regression analysis showed positive correlations between PaO2(Y) to PaO2 (r=0.81, P<0.01) and between OI(Y) and OI (r=0.95, P<0.01). Conclusions: In patients with COPD (especially those with also type II respiratory failure), the modified monitoring method of PCO2 and maintenance of SpO2 above 90% can precisely estimate PaCO2 and PaO2. This method is feasible for clinical noninvasive and dynamic evaluation of respiratory failure in COPD patients, especially in primary care facilities where arterial blood gases analysis is not available.
Avoiding Matrix Inversion in DD SAGE Channel Estimation in MIMO-OFDM with M-QAM

J. Ylioinas,Raghavendra Madanahally,M. Juntti

DOI: https://doi.org/10.1109/VETECF.2009.5378721

2009-09-01

Abstract:A decision directed (DD) channel estimation is considered for a multiple-input multiple-output (MIMO) or- thogonal frequency division multiplexing (OFDM) system to improve the spectral efficiency. Unlike in the pilot based channel estimation, the least-squares (LS) channel estimator operating in the DD mode for MIMO-OFDM requires a matrix inversion. The size of the matrix to be inverted depends on the number of transmit antennas and the length of the channel impulse re- sponse. The frequency domain (FD) space-alternating generalized expectation-maximization (SAGE) channel estimator calculates the LS estimate iteratively avoiding the matrix inversion with a constant envelope modulation. The drawback with the FD- SAGE channel estimator is the required matrix inversion with a non-constant envelope modulation. The size of the matrix to be inverted depends on the length of the channel impulse response. However, it is considerably less complex than the LS channel estimator in the DD mode. In this paper, a time domain (TD) SAGE channel estimator is derived to avoid the matrix inversion in DD channel estimation for MIMO-OFDM systems when using non-constant envelope modulation. The derived TD- SAGE channel estimator is shown to offer the same performance as the FD-SAGE channel estimator with reduced complexity. antennas and the length of the channel impulse response. With constant envelope constellation, the frequency domain (FD) space-alternating expectation-maximization (SAGE) (4) channel estimator avoids this matrix inversion due to dividing the MIMO channel estimation problem into multiple SISO channel estimation problems. However, the drawback of the FD-SAGE channel estimator is that it requires a matrix inver- sion having the number of elements per one dimension equal to the length of the channel impulse response when non-constant envelope constellations are used. In this paper, we derive the DD time domain (TD) SAGE channel estimator for a MIMO-OFDM system. The SISO channel estimation is further divided into multiple single tap estimation problems by the DD-TD-SAGE estimator. The per- formance and the complexity of the DD-TD-SAGE estimator is compared to those of the DD-LS and DD-FD-SAGE estima- tors. As a benchmark, the performance of the preamble-based LS estimation with minimum mean square error (MMSE) post-processing is provided as well. The proposed estimator gives practically the same performance as the DD-FD-SAGE channel estimator without the need for matrix inversion with constant envelope constellations, and, thus, resulting in lower complexity, which is also characterized.
A new structure for VLSI bipolar technology

P. Seegebrecht,Wonchan Kim

DOI: https://doi.org/10.1109/IEDM.1979.189574

Abstract:A novel bipolar process which is complementary to the collector diffused isolation (CDI) process but compatible with the standard buried collector (SBC) process will be presented. The application of it to ECL. and I2L circuits show the advantages of small circuit size and improved performance.
Severe hypoxaemic hypercapnia compounds cerebral oxidative–nitrosative stress during extreme apnoea: Implications for cerebral bioenergetic function

Damian M. Bailey,Anthony R. Bain,Ryan L. Hoiland,Otto F. Barak,Ivan Drvis,Benjamin S. Stacey,Angelo Iannetelli,Gareth W. Davison,Rasmus H. Dahl,Ronan M. G. Berg,David B. MacLeod,Zeljko Dujic,Philip N. Ainslie

DOI: https://doi.org/10.1113/jp285555

2024-02-13

The Journal of Physiology

Abstract:figure legend We determined how physiological extremes of O2 and CO2 impact redox regulation of cerebral bioenergetic function. World‐class breath‐hold divers performed two maximal apnoeas resulting in hypoxaemic hypercapnia (prior normoxic normoventilation) and hyperoxaemic hypercapnia (prior hyperoxic hyperventilation). Transcerebral exchange of ascorbate free radicals (A•−) and nitric oxide metabolites were calculated as the product of global cerebral blood flow (gCBF) and radial arterial (a) to internal jugular venous (v) concentration gradients. Cerebral output (v > a) of A•− was enhanced in hypoxaemic hypercapnia and coincided with greater suppression of plasma nitrite (NO2−) uptake (a > v), gCBF and cerebral metabolic rate of glucose (gCMRGlu), implying reduced consumption and delivery of NO consistent with elevated cerebral oxidative–nitrosative stress (OXNOS). Abbreviations: ICA, internal carotid artery; MCA, middle cerebral artery; PCA, posterior cerebral artery; VA, vertebral artery. Summary interpretation: these findings highlight a key catalytic role for hypoxaemia in cerebral OXNOS, with NO2− reduction most probably serving as the dominant vasoactive mechanism. Figure created using Biorender (https://biorender.com/). We examined the extent to which apnoea‐induced extremes of oxygen demand/carbon dioxide production impact redox regulation of cerebral bioenergetic function. Ten ultra‐elite apnoeists (six men and four women) performed two maximal dry apnoeas preceded by normoxic normoventilation, resulting in severe end‐apnoea hypoxaemic hypercapnia, and hyperoxic hyperventilation designed to ablate hypoxaemia, resulting in hyperoxaemic hypercapnia. Transcerebral exchange of ascorbate radicals (by electron paramagnetic resonance spectroscopy) and nitric oxide metabolites (by tri‐iodide chemiluminescence) were calculated as the product of global cerebral blood flow (by duplex ultrasound) and radial arterial (a) to internal jugular venous (v) concentration gradients. Apnoea duration increased from 306 ± 62 s during hypoxaemic hypercapnia to 959 ± 201 s in hyperoxaemic hypercapnia (P ≤ 0.001). Apnoea generally increased global cerebral blood flow (all P ≤ 0.001) but was insufficient to prevent a reduction in the cerebral metabolic rates of oxygen and glucose (P = 0.015–0.044). This was associated with a general net cerebral output (v > a) of ascorbate radicals that was greater in hypoxaemic hypercapnia (P = 0.046 vs. hyperoxaemic hypercapnia) and coincided with a selective suppression in plasma nitrite uptake (a > v) and global cerebral blood flow (P = 0.034 to <0.001 vs. hyperoxaemic hypercapnia), implying reduced consumption and delivery of nitric oxide consistent with elevated cerebral oxidative–nitrosative stress. In contrast, we failed to observe equidirectional gradients consistent with S‐nitrosohaemoglobin consumption and plasma S‐nitrosothiol delivery during apnoea (all P ≥ 0.05). Collectively, these findings highlight a key catalytic role for hypoxaemic hypercapnia in cerebral oxidative–nitrosative stress. Key points Local sampling of blood across the cerebral circulation in ultra‐elite apnoeists determined the extent to which severe end‐apnoea hypoxaemic hypercapnia (prior normoxic normoventilation) and hyperoxaemic hypercapnia (prior hyperoxic hyperventilation) impact free radical‐mediated nitric oxide bioavailability and global cerebral bioenergetic function. Apnoea generally increased the net cerebral output of free radicals and suppressed plasma nitrite consumption, thereby reducing delivery of nitric oxide consistent with elevated oxidative–nitrosative stress. The apnoea‐induced elevation in global cerebral blood flow was insufficient to prevent a reduction in the cerebral metabolic rates of oxygen and glucose. Cerebral oxidative–nitrosative stress was greater during hypoxaemic hypercapnia compared with hyperoxaemic hypercapnia and coincided with a lower apnoea‐induced elevation in global cerebral blood flow, highlighting a key catalytic role for hypoxaemia. This applied model of voluntary human asphyxia might have broader implications for the management and treatment of neurological diseases characterized by extremes of oxygen demand and carbon dioxide production.

neurosciences,physiology
Is hypocapnia a risk factor for non-invasive ventilation failure in cardiogenic acute pulmonary edema?

Luna Carrillo-Aleman,Elena Carrasco-Gónzalez,Maria João Araújo,Miguel Guia,Nuria Alonso-Fernández,Ana Renedo-Villarroya,Laura López-Gómez,Aurea Higon-Cañigral,Andrés Carrillo-Alcaraz,Juan M. Sanchez-Nieto

DOI: https://doi.org/10.1016/j.jcrc.2022.153991

IF: 4.298

2022-06-01

Journal of Critical Care

Abstract:Introduction and purposeThe impact of hypocapnia in the prognosis of cardiogenic acute pulmonary edema (CAPE) has not been sufficiently studied. The aim of this study was to analyse whether hypocapnia is a risk factor for non-invasive ventilation (NIV) failure and hospital mortality, in CAPE patients CAPE.MethodsRetrospective observational study of all patients with CAPE treated with NIV. Patients were classified in three groups according to PaCO2 level (hypocapnic, eucapnic and hypercapnic). NIV failure was defined as the need for endotracheal intubation and/or death.Results1138 patients were analysed, 390 (34.3%) of which had hypocapnia, 186 (16.3%) had normocapnia and 562 (49.4%) had hypercapnia. NIV failure was more frequent in hypocapnic (60 patients, 15.4%) than in eucapnic (16 pacientes, 8.6%) and hypercapnic group (562 pacientes, 10.7%), with statistical significance (p = 0.027), as well as hospital mortality, 73 (18.7%), 19(10.2%) and 83 (14.8%) respectively (p = 0.026). The predicted factors for NIV failure were the presence of do-not-intubate order, complications related to NIV, a lower left ventricular ejection fraction, higher SAPS II and SOFA score and a higher HACOR score at one hour of NIV initiation.ConclusionsHypocapnia in patients with CAPE is associated with NIV failure and a greater in-hospital mortality.

critical care medicine

Adrenalectomy increases serotonin turnover in brains of obese Zucker rats

Characteristics and Feasibility of Ambulatory Respiratory Assessment of Paediatric Neuromuscular Disease: an Observational Retrospective Study.

[11. Hallux valgus. b). 10-year results after Hohmann's operation in hallux valgus].

"De Novo" Hypercapnic Respiratory Failure Unmasking Neuromuscular Disorders: Experiences From a Tertiary Care Center and Review of Literature

Virulence of Curvularia in a murine model

Effective non-invasive ventilation reduces muscle sympathetic nerve activity in patients with stable hypercapnic COPD

Is Hypercapnia Associated with Poor Prognosis in Chronic Obstructive Pulmonary Disease? A Long-Term Follow-Up Cohort Study.

Association between rate of change in PaCO2 and functional outcome for patients with hypercapnia after out-of-hospital cardiac arrest: Secondary analysis of a randomized clinical trial

Hypercapnia and lung function parameters in chronic obstructive pulmonary disease

Early Fatal Pontocerebellar Hypoplasia with Simplified Cerebral Gyration and Pseudolissencephaly

Determining the effects of elevated partial pressure of oxygen on hypercapnia-induced cerebrovascular reactivity

Androgenic regulation of enzymes involved in DNA synthesis in epididymis of young rats.

Does PaCO2 correction have an impact on survival of patients with chronic respiratory failure and long-term non-invasive ventilation?

Oximetry and carbon dioxide screening for ventilatory requirements in children with spinal muscular atrophy type 1-3

Treatment of squamous cell carcinomas in head and neck with bleomycin and with combined bleomycin and x-rays.

A Narrative Review of the Physiological Rationale and Clinical Evidence

[Application of capnography and SpO2 measurement in the evaluation of respiratory failure in patients with chronic obstructive pulmonary disease]

Avoiding Matrix Inversion in DD SAGE Channel Estimation in MIMO-OFDM with M-QAM

A new structure for VLSI bipolar technology

Severe hypoxaemic hypercapnia compounds cerebral oxidative–nitrosative stress during extreme apnoea: Implications for cerebral bioenergetic function

Is hypocapnia a risk factor for non-invasive ventilation failure in cardiogenic acute pulmonary edema?